BRPI0701085A - uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae - Google Patents

uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae

Info

Publication number
BRPI0701085A
BRPI0701085A BRPI0701085-0A BRPI0701085A BRPI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A
Authority
BR
Brazil
Prior art keywords
receptor antagonist
paf receptor
flaviviridae infections
treat flaviviridae
treat
Prior art date
Application number
BRPI0701085-0A
Other languages
English (en)
Inventor
Teixeira Mauro Martins
Gloria De Souza Danielle Da
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BRPI0701085-0A priority Critical patent/BRPI0701085A/pt
Publication of BRPI0701085A publication Critical patent/BRPI0701085A/pt

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de antagonista do receptor do PAF para o tratamento de infecções causadas por Flaviviridae. A presente invençâo apresenta um novo medicamento de um produto já conhecido com uso no campo médico, para tratar doenças causadas por vírus da família Flaviviridae, especialmente Dengue e Febre de Dengue Hemorrágica (FDH) e Choque.
BRPI0701085-0A 2007-02-27 2007-02-27 uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae BRPI0701085A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0701085-0A BRPI0701085A (pt) 2007-02-27 2007-02-27 uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0701085-0A BRPI0701085A (pt) 2007-02-27 2007-02-27 uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae

Publications (1)

Publication Number Publication Date
BRPI0701085A true BRPI0701085A (pt) 2008-10-14

Family

ID=39832132

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0701085-0A BRPI0701085A (pt) 2007-02-27 2007-02-27 uso de antagonista do receptor do paf para o tratamento de infecções causadas por flaviviridae

Country Status (1)

Country Link
BR (1) BRPI0701085A (pt)

Similar Documents

Publication Publication Date Title
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
MX384206B (es) Formulaciones de inhibidores de dpp iv
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
BR112015013809A2 (pt) derivados de exendina-4 como agonistas duplos de glp1/gip ou trigonais de glp1/gip/lucagon, seu uso e composição farmacêutica
EA201300987A1 (ru) Фармацевтические композиции, включающие метформин и ингибитор dpp-4 или ингибитор sglt-2
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
UY30759A1 (es) Compuestos quimicos
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
EA202091999A3 (ru) Применение ингибиторов dpp iv
ECSP109934A (es) Compuesto - 946
ECSP099685A (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
GT200600045A (es) Derivados de piridizina y su uso como agentes terapeuticos
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
CR20120289A (es) Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
UY30572A1 (es) N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
BRPI0820668A2 (pt) Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
CY1120435T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου
CY1118399T1 (el) Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.

Legal Events

Date Code Title Description
B03A Publication of an application: publication of a patent application or of a certificate of addition of invention
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law
B07A Technical examination (opinion): publication of technical examination (opinion)
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL